I was perusing the Dexcom site after reviewing another thread. As I drilled deeper into the site I came across this information:
Attention Medicare patients: Centers for Medicare & Medicaid Services (CMS) has recently recognized that the Dexcom G5 Mobile CGM System qualifies as durable medical equipment under Medicare Part B. In order to be included in this category, the system must be defined as therapeutic CGM, meaning you can make treatment decisions using the device.
Note: Under the current ruling, the beneficiary may NOT use their smart phone to display glucose data and still be eligible for reimbursement for the purchase of a therapeutic CGM: you cannot use the Dexcom CGM app to display glucose data and be eligible for reimbursement from Medicare.
Am I the only one who finds this to be truly bizarre? I’m referring to the fact that they have just now allowed the G5 (always late to the party, Medicare…), AND not allowing users to access blood glucose information using their smartphone.
Or is this “old news?”
Dawg! Now I’m grinding my teeth again! Gotta’ stop looking at how Medicare handles T1D issues…